STONERIDGE INC (SRI) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:SRI • US86183P1021

9.23 USD
+0.06 (+0.65%)
Last: Feb 11, 2026, 11:38 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

SRI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 42 industry peers in the Automobile Components industry. While SRI seems to be doing ok healthwise, there are quite some concerns on its profitability. SRI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year SRI has reported negative net income.
  • SRI had a positive operating cash flow in the past year.
  • SRI had negative earnings in 4 of the past 5 years.
  • Of the past 5 years SRI 4 years had a positive operating cash flow.
SRI Yearly Net Income VS EBIT VS OCF VS FCFSRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

1.2 Ratios

  • SRI has a Return On Assets of -5.07%. This is in the lower half of the industry: SRI underperforms 66.67% of its industry peers.
  • SRI has a Return On Equity (-12.76%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -5.07%
ROE -12.76%
ROIC N/A
ROA(3y)-1.86%
ROA(5y)-1.27%
ROE(3y)-4.51%
ROE(5y)-3.02%
ROIC(3y)N/A
ROIC(5y)N/A
SRI Yearly ROA, ROE, ROICSRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

  • SRI's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 20.98%, SRI is in line with its industry, outperforming 57.14% of the companies in the same industry.
  • SRI's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for SRI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 20.98%
OM growth 3YN/A
OM growth 5Y-44.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-3.99%
SRI Yearly Profit, Operating, Gross MarginsSRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • SRI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, SRI has more shares outstanding
  • Compared to 5 years ago, SRI has more shares outstanding
  • The debt/assets ratio for SRI is higher compared to a year ago.
SRI Yearly Shares OutstandingSRI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
SRI Yearly Total Debt VS Total AssetsSRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • An Altman-Z score of 2.48 indicates that SRI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of SRI (2.48) is better than 61.90% of its industry peers.
  • The Debt to FCF ratio of SRI is 7.28, which is on the high side as it means it would take SRI, 7.28 years of fcf income to pay off all of its debts.
  • SRI has a Debt to FCF ratio of 7.28. This is comparable to the rest of the industry: SRI outperforms 59.52% of its industry peers.
  • SRI has a Debt/Equity ratio of 0.68. This is a neutral value indicating SRI is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.68, SRI is in line with its industry, outperforming 42.86% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 7.28
Altman-Z 2.48
ROIC/WACCN/A
WACC9.82%
SRI Yearly LT Debt VS Equity VS FCFSRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

2.3 Liquidity

  • SRI has a Current Ratio of 2.13. This indicates that SRI is financially healthy and has no problem in meeting its short term obligations.
  • With a decent Current ratio value of 2.13, SRI is doing good in the industry, outperforming 64.29% of the companies in the same industry.
  • SRI has a Quick Ratio of 1.33. This is a normal value and indicates that SRI is financially healthy and should not expect problems in meeting its short term obligations.
  • SRI's Quick ratio of 1.33 is fine compared to the rest of the industry. SRI outperforms 61.90% of its industry peers.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.33
SRI Yearly Current Assets VS Current LiabilitesSRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • SRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -383.33%.
  • The Revenue has decreased by -4.92% in the past year.
  • Measured over the past years, SRI shows a small growth in Revenue. The Revenue has been growing by 1.71% on average per year.
EPS 1Y (TTM)-383.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)-4.92%
Revenue growth 3Y5.64%
Revenue growth 5Y1.71%
Sales Q2Q%-1.67%

3.2 Future

  • Based on estimates for the next years, SRI will show a very strong growth in Earnings Per Share. The EPS will grow by 22.71% on average per year.
  • The Revenue is expected to decrease by -0.23% on average over the next years.
EPS Next Y-125.64%
EPS Next 2Y22.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-6.47%
Revenue Next 2Y-0.23%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SRI Yearly Revenue VS EstimatesSRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
SRI Yearly EPS VS EstimatesSRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for SRI. In the last year negative earnings were reported.
  • Also next year SRI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SRI Price Earnings VS Forward Price EarningsSRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SRI is on the same level as its industry peers.
  • Based on the Price/Free Cash Flow ratio, SRI is valued a bit cheaper than the industry average as 78.57% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11
EV/EBITDA 13.84
SRI Per share dataSRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • SRI's earnings are expected to grow with 22.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.71%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • SRI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

STONERIDGE INC

NYSE:SRI (2/11/2026, 11:38:53 AM)

9.23

+0.06 (+0.65%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)11-05
Earnings (Next)03-11
Inst Owners86.47%
Inst Owner Change0.58%
Ins Owners2.26%
Ins Owner Change0%
Market Cap258.62M
Revenue(TTM)874.36M
Net Income(TTM)-32.04M
Analysts84
Price Target16.32 (76.81%)
Short Float %1.3%
Short Ratio2.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.55%
Min Revenue beat(2)1.3%
Max Revenue beat(2)1.8%
Revenue beat(4)3
Avg Revenue beat(4)0.84%
Min Revenue beat(4)-2.68%
Max Revenue beat(4)2.92%
Revenue beat(8)4
Avg Revenue beat(8)-0.51%
Revenue beat(12)7
Avg Revenue beat(12)0.72%
Revenue beat(16)11
Avg Revenue beat(16)3.35%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-700%
EPS NY rev (1m)0%
EPS NY rev (3m)-150%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.3
P/FCF 11
P/OCF 5.82
P/B 1.03
P/tB 1.5
EV/EBITDA 13.84
EPS(TTM)-0.87
EYN/A
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)0.84
FCFY9.09%
OCF(TTM)1.59
OCFY17.18%
SpS31.2
BVpS8.96
TBVpS6.17
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.07%
ROE -12.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 20.98%
FCFM 2.69%
ROA(3y)-1.86%
ROA(5y)-1.27%
ROE(3y)-4.51%
ROE(5y)-3.02%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.54%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-44.52%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-3.99%
F-Score5
Asset Turnover1.38
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 7.28
Debt/EBITDA 6.29
Cap/Depr 62.27%
Cap/Sales 2.39%
Interest Coverage N/A
Cash Conversion 164.3%
Profit Quality N/A
Current Ratio 2.13
Quick Ratio 1.33
Altman-Z 2.48
F-Score5
WACC9.82%
ROIC/WACCN/A
Cap/Depr(3y)90.27%
Cap/Depr(5y)89.37%
Cap/Sales(3y)3.38%
Cap/Sales(5y)3.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-383.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y-125.64%
EPS Next 2Y22.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.92%
Revenue growth 3Y5.64%
Revenue growth 5Y1.71%
Sales Q2Q%-1.67%
Revenue Next Year-6.47%
Revenue Next 2Y-0.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-152.66%
EBIT growth 3YN/A
EBIT growth 5Y-43.57%
EBIT Next Year113.42%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y295.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.75%
OCF growth 3YN/A
OCF growth 5Y14.27%

STONERIDGE INC / SRI FAQ

What is the fundamental rating for SRI stock?

ChartMill assigns a fundamental rating of 2 / 10 to SRI.


Can you provide the valuation status for STONERIDGE INC?

ChartMill assigns a valuation rating of 2 / 10 to STONERIDGE INC (SRI). This can be considered as Overvalued.


How profitable is STONERIDGE INC (SRI) stock?

STONERIDGE INC (SRI) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for SRI stock?

The Earnings per Share (EPS) of STONERIDGE INC (SRI) is expected to decline by -125.64% in the next year.